Emergent BioSolutions (EBS) EBITDA Margin Growth (1y) (2012 - 2026)
Emergent BioSolutions (EBS) EBITDA Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 304.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -157.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -650.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -3,172.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2,080.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 152.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -17,785.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,472.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -583.00 |
| 10 | Emergent BioSolutions | 412.09 Mn | 250.59 Mn | 84.10 Mn | -1,573.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,573.00 |
| Dec 31, 2025 | -1,388.00 |
| Sep 30, 2025 | 1,115.00 |
| Jun 30, 2025 | 40,814.00 |
| Mar 31, 2025 | 921.00 |
| Dec 31, 2024 | 1,096.00 |
| Sep 30, 2024 | 11,145.00 |
| Jun 30, 2024 | -32,032.00 |
| Mar 31, 2024 | 10,308.00 |
| Dec 31, 2023 | 91.00 |
| Sep 30, 2023 | -7,062.00 |
| Jun 30, 2023 | -5,523.00 |
| Mar 31, 2023 | -9,210.00 |
| Dec 31, 2022 | -5,588.00 |
| Sep 30, 2022 | -327.00 |
| Jun 30, 2022 | -3,333.00 |
| Mar 31, 2022 | -2,219.00 |
| Dec 31, 2021 | -514.00 |
| Sep 30, 2021 | -3,153.00 |
| Jun 30, 2021 | -3,004.00 |